Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06508450 · ClinicalTrials.gov registry record · NA
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
A NA study of Depressive Disorder and Psychosis, sponsored by New York University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06508450: Recruiting NA study of Depressive Disorder and Psychosis, sponsored by New York University.
NCT06508450 is a NA study of Depressive Disorder and Psychosis that is actively recruiting participants, run by New York University. The registered enrollment target is 80 participants, below the 330-participant average among 47 other Depressive Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06508450, a NA study of Depressive Disorder and Psychosis, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers aim to test a brief culturally-responsive young adult orientation program for community mental health services. They will conduct a 24-month randomized trial with 80 young adults from racial and ethnic minority groups in a community-based mental health clinic.
Primary Outcome
Self-report measure for assessing intervention acceptability from the perspectives of intervention recipients. Based on the theoretical framework of acceptability. Items are scored from 1 to 5. Possible total scores range from 9 to 45, with higher scores indicating greater acceptability.
Conditions Studied
Interventions
- BEHAVIORAL Just Do You
- BEHAVIORAL Component A
- BEHAVIORAL Component B
- BEHAVIORAL Component C
Study Locations (1)
New York
- The Jewish Board - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-12-18 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT06508450 shows while recruiting
NCT06508450 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 330-participant average among 47 other Depressive Disorder trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Depressive Disorder appearing as the primary indexed condition, and to 4 interventions - of which Just Do You is the first listed.
NCT06508450 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06508450 about?
NCT06508450 is a clinical study titled "A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults". Researchers aim to test a brief culturally-responsive young adult orientation program for community mental health services. They will conduct a 24-month randomized trial with 80 young adults from racial and ethnic minority groups in a community-based mental health clinic.
What is the current status of trial NCT06508450?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-12-18. Estimated completion is 2027-03.
What conditions does trial NCT06508450 study?
This clinical trial studies the following conditions: Depressive Disorder, Psychosis, Bipolar and Related Disorders.
What interventions are being tested in trial NCT06508450?
The interventions under investigation include: Just Do You (BEHAVIORAL), Component A (BEHAVIORAL), Component B (BEHAVIORAL), Component C (BEHAVIORAL).
Who is sponsoring clinical trial NCT06508450?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06508450 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06508450's enrollment target sits among peer trials
80 27th of 47 higher than 21 of 47 other Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
-
Measurement-Based Care (MBC) Implementation, Effectiveness, and Mechanisms of Change
RECRUITING · NA
-
Research Evaluating Vagal Excitation AND Anatomical Links
RECRUITING · NA
-
Unified Protocol: Community Connections
RECRUITING · NA
-
Enhancing Brain And Mental Health Through Breathing Practice
RECRUITING · NA
-
Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI